| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
| SERIAL NUMBER |
85072755 |
| LAW OFFICE ASSIGNED |
LAW OFFICE 103 |
| MARK SECTION |
| OWNER SECTION (no change) |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| CURRENT IDENTIFICATION |
Iontophoretic transdermal drug delivery skin patch sold with medication for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular,
cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related
diseases and disorders |
| GOODS OR SERVICES |
KEEP ALL LISTED |
| EXTENSION SECTION |
| EXTENSION NUMBER |
1 |
| ALLOWANCE MAIL DATE |
04/12/2011 |
| STATEMENT OF USE |
NO |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| SUBTOTAL AMOUNT |
150 |
| TOTAL AMOUNT |
150 |
| SIGNATURE SECTION |
| SIGNATURE |
/Suzanne M. Hanlon/ |
| SIGNATORY'S NAME |
Suzanne M. Hanlon |
| SIGNATORY'S POSITION |
Associate General Counsel |
| DATE SIGNED |
10/06/2011 |
| FILING INFORMATION |
| SUBMIT DATE |
Thu Oct 06 15:08:35 EDT 2011 |
| TEAS STAMP |
USPTO/ESU-XX.XX.XXX.XXX-2
0111006150835068591-85072
755-480512e9623f9ec53f932
e9dabdaf2aa43-DA-1372-201
11006115623453632 |
| PTO Form 1581 (Rev 9/2005) |
| OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: SMARTRELIEF
SERIAL NUMBER: 85072755
The applicant, NuPathe Inc., having an address of
227 Washington Street, Suite 200
Conshohocken, Pennsylvania 19428
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 04/12/2011.
For International Class 005:
Current identification: Iontophoretic transdermal drug delivery skin patch sold with medication for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary,
genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and
disorders
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the first extension request.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements may jeopardize the validity of the form or any resulting registration, declares that he/she is properly authorized to execute this form on behalf of the applicant; he/she believes the
applicant to be the owner of the trademark/service mark sought to be registered; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief
are believed to be true.
Signature: /Suzanne M. Hanlon/ Date Signed: 10/06/2011
Signatory's Name: Suzanne M. Hanlon
Signatory's Position: Associate General Counsel
RAM Sale Number: 1372
RAM Accounting Date: 10/07/2011
Serial Number: 85072755
Internet Transmission Date: Thu Oct 06 15:08:35 EDT 2011
TEAS Stamp: USPTO/ESU-XX.XX.XXX.XXX-2011100615083506
8591-85072755-480512e9623f9ec53f932e9dab
daf2aa43-DA-1372-20111006115623453632